Opportunities and Challenges for a Histology-Agnostic Utilization of Trastuzumab Deruxtecan.
Curr Oncol Rep
; 25(12): 1467-1482, 2023 Dec.
Article
in En
| MEDLINE
| ID: mdl-37938529
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Carcinoma, Non-Small-Cell Lung
/
Immunoconjugates
/
Cancer Vaccines
/
Lung Neoplasms
Limits:
Female
/
Humans
Language:
En
Journal:
Curr Oncol Rep
Journal subject:
NEOPLASIAS
Year:
2023
Document type:
Article
Affiliation country:
United States
Country of publication:
United States